|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||||||||
|
||||||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s6997E752-5E16-11EF-9592-638585CE164B&I=39IZM&T=&OP=Display&O=html&O1=15599389&O2=954925539165&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3D72-Week%2520Safety%2520and%2520Tolerability%2520of%2520Dimethyl%2520Fumarate%2520in%2520Japanese%2520Patients%2520with%2520Relapsing-remitting%2520Multiple%2520Sclerosis%253A%2520Analysis%2520of%2520the%2520Randomised%252C%2520Double%2520Blind%252C%2520Placebo-Controlled%252C%2520Phase%2520III%2520APEX%2520Study%2520and%2520its%2520Open-Label%2520Extension%26rft.au%3DHiramatsu%252C%2520Katsutoshi%26rft.au%3DNiino%252C%2520Masaaki%26rft.au%3DOchi%252C%2520Hirofumi%26rft.au%3DOnizuka%252C%2520Yasuhiro%26rft.date%3D2018-10-01%26rft.eissn%3D1865-8652%26rft.epage%3D1611%26rft.externalDocID%3D10_1007_s12325_018_0788_8%26rft.genre%3Darticle%26rft.issn%3D0741-238X%26rft.issue%3D10%26rft.jtitle%3DAdvances%2520in%2520therapy%26rft.pub%3DSpringer%2520Healthcare%26rft.spage%3D1598%26rft.volume%3D35%26rft_id%3Dinfo%253Adoi%252F10.1007%252Fs12325-018-0788-8%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-SPRINGER_LINK_JOURNALS_AUTOLOAD_FIS_20231124_LCL-getFullTxt-object,2-SPRINGER_LINK_JOURNALS_AUTOLOAD_konzorcij_20230517_LCL-getFullTxt-object,3-UNPAYWALL-getFullTxt-object,4-DOI-getDOI-object,5-COBIB_SI_LCL-getHolding-object,6-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,7-NCBI_PUBMED_FREE-getAbstract-object,8-EBSCOHOST_CINAHL_WITH_FULL_TEXT-getTOC-object,9-EBSCOHOST_CINAHL_WITH_FULL_TEXT_UL_2024_04_LCL-getTOC-object,10-ISI_WEB_OF_SCIENCE-getAuthor-object,11-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,12-REFWORKS_EXPORT_TOOL-getReference-object,13-SHERPA_RoMEO_LCL-getWebService-object,14-GOOGLE_SCHOLAR_FREE-getWebSearch-object,15-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.045807&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15599389-s6997E752-5E16-11EF-9592-638585CE164B" timestamp="2024-08-19T12:33:18Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925539165</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>72-Week Safety and Tolerability of Dimethyl Fumarate in Japanese Patients with Relapsing-remitting Multiple Sclerosis: Analysis of the Randomised, Double Blind, Placebo-Controlled, Phase III APEX Study and its Open-Label Extension</jnl:atitle>
<jnl:jtitle>Advances in Therapy</jnl:jtitle>
<jnl:date>2018-10-00</jnl:date>
<jnl:spage>1598</jnl:spage>
<jnl:epage>1611</jnl:epage>
<jnl:coden>ADTHE7</jnl:coden>
<jnl:issn>0741-238X</jnl:issn>
<jnl:volume>35</jnl:volume>
<jnl:issue>10</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1865-8652</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>ADTHE7</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:6b0cafe04e12e4813da34d16265b8e7ec2d66154</ctx:identifier>
<ctx:identifier>urn:UUID:s6997E752-5E16-11EF-9592-638585CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)